Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Acyclic nucleotide analogs as well as preparation method and application thereof

A technology of acyclic nucleotides and analogues, which is applied in the field of chemical synthesis of drugs and can solve problems such as drug resistance and side effects

Active Publication Date: 2013-01-23
SICHUAN GOODDOCTOR PANXI PHARMA +1
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In summary, although open-ring nucleoside drugs have been greatly developed, there are still problems such as drug resistance and high toxicity. Therefore, exploring and developing new antiviral drugs is still an urgent research topic

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Acyclic nucleotide analogs as well as preparation method and application thereof
  • Acyclic nucleotide analogs as well as preparation method and application thereof
  • Acyclic nucleotide analogs as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0089] The preparation of embodiment 1 (R)-1-(2-hydroxypropyl)-4-aminopyrazolo[3,4-d]pyrimidine

[0090]

[0091] Add 5.26g of 4-aminopyrazolo[3,4-d]pyrimidine to a 250mL round bottom flask, then add 200mL of DMF and 83mg of sodium hydroxide, heat the reaction solution to 140°C, slowly add 3.90mL of R-carbonic acid Acrylate, react at 140°C for 16 hours after addition. TLC (DCM:MeOH=8:1) detected that the reaction was complete. The solvent was distilled off under reduced pressure and separated by silica gel column chromatography to obtain 5.55 g of a white solid with a yield of 74.7%.

[0092] 1 H NMR (DMSO-d 6 ,400Hz)δ8.16(s,1H),8.08(s,1H),7.63(s,2H),4.28-4.22(m,1H),4.13(d,2H,J=5.6Hz),3.37(s ,1H), 1.03(d,3H,J=5.6Hz).

Embodiment 2

[0093] Example 2 (R)-N 4 - Preparation of dimethylaminomethylene-1-(2-hydroxypropyl)-pyrazolo[3,4-d]pyrimidine

[0094]

[0095] In a 100mL flask, add 11.24g (R)-1-(2-hydroxypropyl)-4-aminopyrazolo[3,4-d]pyrimidine, 23.5mLN,N-dimethylformamide dimethyl acetal (DMF-DMA), and then add 50 mL of chloroform. Under nitrogen protection, stir overnight at room temperature. TLC detection (DCM:MeOH=9:1) until the reaction is complete. The solvent was distilled off under reduced pressure to obtain a pale yellow oil, which was separated by silica gel column chromatography to obtain 11.4 g of a white solid with a yield of 78.9%.

Embodiment 3

[0096] Example 3 (R)-N 4 - Preparation of dimethylaminomethylene-1-[2-bis(ethylphosphonomethoxy)propyl]-pyrazolo[3,4-d]pyrimidine

[0097]

[0098] In a 500mL flask, add 11.4g (R)-N 4 -Dimethylaminomethylene-1-(2-hydroxypropyl)-pyrazolo[3,4-d]pyrimidine and 14.1 mL of diethyl p-toluenesulfonyloxymethylphosphonate, then 300 mL of toluene was added, Add 5.51gNaH under ice-salt bath. Under nitrogen protection, stir overnight at room temperature. TLC detection (DCM:MeOH=10:1) until the reaction was complete. The solvent was distilled off under reduced pressure, the solid was dissolved in 100ml of dichloromethane, and glacial acetic acid was added drop by drop under stirring to adjust the pH to 8-9. It was extracted three times with dichloromethane, dried over anhydrous magnesium sulfate, and distilled under reduced pressure to obtain a yellow oil. Separated by silica gel column chromatography, 11.01 g of a white solid was obtained with a yield of 60.2%. 1 HNMR (CDCl 3 ,400...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of chemical synthetic drugs, and particularly relates to acyclic nucleotide analogs as well as a preparation method and an application of the acyclic nucleotide analogs in antiviral drugs. The technical problem to be solved by the invention is to provide a new class of acyclic nucleotide analogs which has the structure shown as the formula I. The acyclic nucleotide analogs provided by the invention has an antiviral pesticide effect, and provides a new choice for the development of antiviral drugs.

Description

technical field [0001] The invention belongs to the technical field of chemically synthesized drugs, and in particular relates to an acyclic nucleotide analogue, a preparation method thereof and an application in antiviral drugs. Background technique [0002] Diseases caused by viral infections such as viral hepatitis and AIDS are major diseases that seriously threaten human health. International research on antiviral drugs has made important progress, and some clinically effective antiviral drugs have been found, such as interferon, lamivudine, telbivudine, clavudine, entecavir, adefovir dipivoxil, Nofovir dipivoxil, zidovudine, stavudine, nevirapine, indinavir and valacyclovir, etc. As an important family of nucleoside antiviral drugs, ring-opening nucleoside compounds have low toxicity, good tolerance and broad-spectrum anti-DNA virus activity, and have a strong killing effect on drug-resistant strains, and play an important role in the field of antiviral therapy. Among...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D487/04C07F9/6512C07F9/6571C07F9/6574C07F9/6584A61K31/675A61P31/14A61P31/18A61P31/20
CPCC07F9/141C07F9/65515C07D487/04C07F9/653A61P31/14A61P31/18A61P31/20C07F9/6561C07F9/657181C07F9/65846
Inventor 谢永美魏于全李炯
Owner SICHUAN GOODDOCTOR PANXI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com